Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.740
-0.030 (-1.69%)
At close: May 13, 2026, 4:00 PM EDT
1.830
+0.090 (5.17%)
After-hours: May 13, 2026, 6:27 PM EDT
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $12.53 million as of May 13, 2026. Its market cap has decreased by -48.09% in one year.
Market Cap
12.53M
Enterprise Value
2.52M
1-Year Change
-48.09%
Ranking
Category
Stock Price
$1.74
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $12.53M, a decrease of -98.02%. That is a compound annual growth rate of -53.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 12.53M | 23.36% |
| Dec 31, 2025 | 10.16M | -70.24% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vyome Holdings | 13.90M |
| Cyclerion Therapeutics | 13.44M |
| BioLineRx | 13.43M |
| Intensity Therapeutics | 12.93M |
| Phio Pharmaceuticals | 12.78M |
| Psyence Biomedical | 12.77M |
| Hoth Therapeutics | 12.62M |
| Moleculin Biotech | 12.49M |